Publication Information

{'id': 'https://openalex.org/W2565149395', 'doi': 'https://doi.org/10.1158/1538-7445.am2015-728', 'title': 'Abstract 728: New derivative of galiellalactone inhibits the STAT3 activity and suppresses ENZ-resistant Prostate Cancerin vitro', 'display_name': 'Abstract 728: New derivative of galiellalactone inhibits the STAT3 activity and suppresses ENZ-resistant Prostate Cancerin vitro', 'publication_year': 2015, 'publication_date': '2015-08-01', 'ids': {'openalex': 'https://openalex.org/W2565149395', 'doi': 'https://doi.org/10.1158/1538-7445.am2015-728', 'mag': '2565149395'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2015-728', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5056176506', 'display_name': 'Daksh Thaper', 'orcid': None}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Daksh Thaper', 'raw_affiliation_strings': ['1Vancouver Prostate Centre, Vancouver, British Columbia, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Centre, Vancouver, British Columbia, Canada;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055642554', 'display_name': 'Sepideh Vahid', 'orcid': None}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Sepideh Vahid', 'raw_affiliation_strings': ['1Vancouver Prostate Centre, Vancouver, British Columbia, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Centre, Vancouver, British Columbia, Canada;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102968181', 'display_name': 'Jennifer L. Bishop', 'orcid': 'https://orcid.org/0000-0003-3676-8743'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Jennifer L. Bishop', 'raw_affiliation_strings': ['1Vancouver Prostate Centre, Vancouver, British Columbia, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Centre, Vancouver, British Columbia, Canada;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077167332', 'display_name': 'Martin Johansson', 'orcid': 'https://orcid.org/0000-0001-8510-3102'}, 'institutions': [{'id': 'https://openalex.org/I4210104173', 'display_name': 'Glactone Pharma (Sweden)', 'ror': 'https://ror.org/01azp7v94', 'country_code': 'SE', 'type': 'company', 'lineage': ['https://openalex.org/I4210104173']}], 'countries': ['SE'], 'is_corresponding': False, 'raw_author_name': 'Martin Johansson', 'raw_affiliation_strings': ['2Glactone Pharma Development AB, Helsingborg, Sweden.'], 'affiliations': [{'raw_affiliation_string': '2Glactone Pharma Development AB, Helsingborg, Sweden.', 'institution_ids': ['https://openalex.org/I4210104173']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5081653545', 'display_name': 'Amina Zoubeidi', 'orcid': 'https://orcid.org/0000-0002-0498-142X'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Amina Zoubeidi', 'raw_affiliation_strings': ['1Vancouver Prostate Centre, Vancouver, British Columbia, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Centre, Vancouver, British Columbia, Canada;', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.516351, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 66, 'max': 73}, 'biblio': {'volume': '75', 'issue': '15_Supplement', 'first_page': '728', 'last_page': '728'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9963, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9963, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12465', 'display_name': 'Cancer, Lipids, and Metabolism', 'score': 0.964, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10756', 'display_name': 'Estrogen and related hormone effects', 'score': 0.9441, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/enzalutamide', 'display_name': 'Enzalutamide', 'score': 0.61357355}], 'concepts': [{'id': 'https://openalex.org/C2778923194', 'wikidata': 'https://www.wikidata.org/wiki/Q14912019', 'display_name': 'STAT3', 'level': 3, 'score': 0.7712592}, {'id': 'https://openalex.org/C2779723316', 'wikidata': 'https://www.wikidata.org/wiki/Q6459234', 'display_name': 'LNCaP', 'level': 4, 'score': 0.76532865}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.71833163}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.6344396}, {'id': 'https://openalex.org/C2776551883', 'wikidata': 'https://www.wikidata.org/wiki/Q1996756', 'display_name': 'Enzalutamide', 'level': 5, 'score': 0.61357355}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.6094281}, {'id': 'https://openalex.org/C81885089', 'wikidata': 'https://www.wikidata.org/wiki/Q189082', 'display_name': 'Cell culture', 'level': 2, 'score': 0.47369838}, {'id': 'https://openalex.org/C171958077', 'wikidata': 'https://www.wikidata.org/wiki/Q419333', 'display_name': 'STAT protein', 'level': 4, 'score': 0.44746926}, {'id': 'https://openalex.org/C62112901', 'wikidata': 'https://www.wikidata.org/wiki/Q189159', 'display_name': 'Cell growth', 'level': 2, 'score': 0.43393087}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.39053667}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.38352293}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.38098407}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.3266856}, {'id': 'https://openalex.org/C62478195', 'wikidata': 'https://www.wikidata.org/wiki/Q828130', 'display_name': 'Signal transduction', 'level': 2, 'score': 0.27723482}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.24927053}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.20929697}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.07206175}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2015-728', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.74, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4362621793', 'https://openalex.org/W4362621709', 'https://openalex.org/W4362609326', 'https://openalex.org/W4362609250', 'https://openalex.org/W4362495275', 'https://openalex.org/W4362495086', 'https://openalex.org/W2991319487', 'https://openalex.org/W2767048879', 'https://openalex.org/W2737056430', 'https://openalex.org/W2561061456'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'The': [2, 248], 'role': [3], 'of': [4, 9, 16, 55, 73, 81, 98, 126, 181, 252, 259, 284, 323, 329, 341, 381, 388, 402, 432, 439, 469, 485, 490], 'signal': [5], 'transducer': [6], 'and': [7, 83, 174, 183, 198, 227, 279, 293, 301, 313, 326, 374, 475], 'activator': [8], 'transcription': [10], '(STAT)': [11], '3': [12], 'in': [13, 25, 65, 108, 134, 163, 250, 267, 271, 364, 396, 435, 480], 'the': [14, 20, 35, 53, 74, 127, 139, 156, 240, 359, 400, 414, 430, 472, 486, 491], 'progression': [15], 'Prostate': [17, 478], 'Cancer': [18, 479, 495, 505], '(PCa),': [19], 'most': [21, 36, 44], 'common': [22], 'male': [23], 'cancer': [24, 50, 451], 'North': [26], 'America,': [27], 'is': [28, 78, 144], 'well': [29, 337, 368, 378], 'established.': [30], 'Although': [31], 'androgen': [32, 75], 'ablation': [33], 'remains': [34, 110], 'effective': [37, 422], 'therapy': [38], 'for': [39, 295, 494], 'patients': [40, 427], 'with': [41, 165, 275, 291, 309, 404, 413], 'advanced': [42], 'disease,': [43], 'progress': [45], 'to': [46, 106, 131, 207, 222, 239, 245, 409, 424], 'castrate': [47], 'resistant': [48, 406], 'prostate': [49], '(CRPC).': [51], 'Despite': [52], 'development': [54], 'new': [56], 'potent': [57], 'anti-androgens,': [58], 'like': [59, 299, 345], 'Enzalutamide': [60], '(ENZ),': [61], 'which': [62], 'prolongs': [63], 'survival': [64], 'CRPC': [66, 82, 96, 109, 208, 246, 268, 280, 370, 407, 436], 'patients,': [67], 'ENZ': [68, 107, 365, 405, 433], 'resistance': [69, 105, 366, 390, 434], 'rapidly': [70], 'occurs.': [71], 'Re-activation': [72], 'receptor': [76], '(AR)': [77], 'a': [79, 178, 314, 392], 'hallmark': [80], 'can': [84, 94], 'occur': [85], 'via': [86, 437], 'different': [87], 'mechanisms,': [88], 'including': [89], 'STAT3': [90, 93, 103, 128, 154, 204, 241, 285, 330, 342, 360, 412, 473], 'activation.': [91], 'Furthermore,': [92], 'promote': [95], 'independently': [97], 'AR': [99, 140, 200, 277, 287, 296, 311, 375, 440], 'activity,': [100], 'however': [101], 'whether': [102], 'promotes': [104], 'unknown.': [111], 'We': [112, 176], 'have': [113], 'found': [114, 184], 'that': [115, 152, 185, 213, 232, 357], 'our': [116], 'LNCaP': [117], 'xenograft': [118], 'derived': [119, 188], 'ENZR': [120, 171, 192, 215, 233, 255, 272, 307, 389, 426], 'cell': [121, 186, 216, 234, 273, 316, 372, 383, 447], 'lines': [122, 187, 217, 235, 274], 'exhibit': [123], 'higher': [124], 'activity': [125, 201, 278, 288, 312, 331, 376, 441, 474], 'pathway': [129, 361], 'compared': [130, 206, 221, 244], 'CRPC.': [132, 172, 223], 'Additionally,': [133], 'this': [135, 351], 'model': [136, 180], 'further': [137], 'targeting': [138, 153, 358], 'using': [141, 155, 362], 'novel': [142], 'anti-androgens': [143, 166], 'short': [145], 'lived': [146], 'or': [147, 162, 169, 428], 'ineffective.': [148], 'Therefore,': [149], 'we': [150, 353], 'propose': [151], 'small': [157, 415], 'molecule': [158, 416], 'inhibitor': [159, 242, 417], 'GPA500,': [160], 'alone': [161], 'combination': [164], 'may': [167, 419], 'delay': [168, 429], 'treat': [170, 425], 'Methods': [173], 'Results:': [175], 'developed': [177], 'unique': [179], 'ENZ-resistance': [182], 'from': [189], 'serially': [190], 'passaged': [191], 'tumors': [193], 'displayed': [194], 'broad': [195], 'genetic': [196], 'diversity': [197], 'differential': [199], 'but': [202], 'consistent': [203], 'hyper-activation': [205], 'controls.': [209], 'WB': [210, 292, 335], 'analysis': [211, 340], 'showed': [212, 231], 'all': [214], 'had': [218], 'increased': [219], 'pSTAT3Y705': [220], 'Accordingly,': [224], 'Crystal': [225], 'Violet': [226], 'MTT': [228], 'proliferation': [229, 373], 'assays': [230], 'were': [236], 'more': [237], 'sensitive': [238], 'GPA500': [243, 253, 263, 318, 363, 418], 'control.': [247], 'reduction': [249, 438], 'growth': [251], 'treated': [254], 'cells': [256, 308], 'was': [257, 332], 'independent': [258], 'PARP': [260, 265], 'cleavage,': [261], 'whereas': [262], 'induced': [264], 'cleavage': [266], 'cells.': [269, 453], 'Moreover,': [270], 'high': [276], 'control': [281], 'cells,': [282], 'inhibition': [283], 'reduced': [286, 320], 'as': [289, 336, 338, 367, 369, 377, 379, 399, 450], 'shown': [290], 'qRT-PCR': [294, 339], 'downstream': [297], 'targets': [298], 'PSA': [300], 'an': [302, 421], 'AR-luciferase': [303], 'reporter': [304], 'assay.': [305], 'In': [306, 350], 'low': [310], 'stem': [315, 382, 452], 'phenotype,': [317], 'treatment': [319], 'surface': [321], 'expression': [322, 380], 'α2β1,': [324], 'CD44': [325], 'CD133.': [327], 'Inhibition': [328], 'confirmed': [333], 'by': [334, 443], 'regulated': [343], 'genes': [344], 'c-Myc,': [346], 'MCL1,': [347], 'BCL-XL.': [348], 'Conclusion:': [349], 'study,': [352], 'provide': [354, 420], 'pre-clinical': [355], 'proof': [356], 'reduces': [371], 'markers.': [384], 'Impact:': [385], 'Exploring': [386], 'mechanisms': [387], 'serves': [391], 'critical': [393], 'unmet': [394], 'need': [395], 'PCa': [397], 'oncology,': [398], 'number': [401], 'men': [403], 'continues': [408], 'rise.': [410], 'Targeting': [411], 'method': [423], 'emergence': [431], 'and/or': [442], 'suppressing': [444], 'aggressive': [445], 'tumor': [446], 'phenotypes': [448], 'such': [449], 'Citation': [454], 'Format:': [455], 'Daksh': [456], 'Thaper,': [457], 'Sepideh': [458], 'Vahid,': [459], 'Jennifer': [460], 'L.': [461], 'Bishop,': [462], 'Martin': [463], 'Johansson,': [464], 'Amina': [465], 'Zoubeidi.': [466], 'New': [467], 'derivative': [468], 'galiellalactone': [470], 'inhibits': [471], 'suppresses': [476], 'ENZ-resistant': [477], 'vitro.': [481], '[abstract].': [482], 'In:': [483], 'Proceedings': [484], '106th': [487], 'Annual': [488], 'Meeting': [489], 'American': [492], 'Association': [493], 'Research;': [496], '2015': [497], 'Apr': [498], '18-22;': [499], 'Philadelphia,': [500], 'PA.': [501], 'Philadelphia': [502], '(PA):': [503], 'AACR;': [504], 'Res': [506], '2015;75(15': [507], 'Suppl):Abstract': [508], 'nr': [509], '728.': [510], 'doi:10.1158/1538-7445.AM2015-728': [511]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2565149395', 'counts_by_year': [{'year': 2020, 'cited_by_count': 1}], 'updated_date': '2024-12-12T01:26:58.971493', 'created_date': '2017-01-06'}